| Ytd | 1.62% | |
| 1y | 40.11% |
| Open | 774.47 | Prev Close | 772.11 | Low | 767.82 | High | 785.98 | Mkt Cap | 80.81B |
| Vol | 551.22K | Avg Vol | 1.03M | EPS | 45.63 | P/E | 17.19 | Forward P/E | 14.81 |
| Beta | 0.24 | Short Ratio | 3.20 | Inst. Own | 92.18% | Dividend | 3.76 | Div Yield | 0.57 |
| Ex Div Date | 05-20 | Earning | 07-30 | 50-d Avg | 645.87 | 200-d Avg | 710.67 | 1yr Est | 822.45 |
REGN News
SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh
LOS ANGELES, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Rege
Institutional investors with REGN positions may need to assess alleged clinical-trial disclosure fai
SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in
Regeneron (REGN) shares have started gaining and might continue moving higher in the near term, as i
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider
New York, New York--(Newsfile Corp. - August 5, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud
Ryan Crowe Regeneron securities defendant liability allegations focus on investor-facing statements
SAN DIEGO, Calif.--(BUSINESS WIRE)---- $REGN #Health--Robbins LLP reminds investors that a securitie
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Rege
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SueWallSt alerts investors in Regeneron Pharmaceuticals,
LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholder
A securities fraud class action lawsuit has been filed on behalf of Regeneron investors after its st
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
SAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals (NASDAQ: REGN) faces a se
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
New York, New York--(Newsfile Corp. - August 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nation
Market impact notice: REGN shares allegedly lost $102.09 from the Class Period high after disclosure
BENGALURU, India & BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #biosimilar--Biocon Announces U.S. Commercia
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Di
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit wit
LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigat
LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action laws
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
Bank of America Corp DE raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 2.8
SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Regeneron Pharmaceuticals (NASDAQ: REGN) faces a securi
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh
Early-career scientists from New York University, Stanford University and Rensselaer Polytechnic Ins
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Piper Sandler analyst Biren Amin maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overwei
Morgan Stanley analyst Matthew Harrison maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Secto
Truist Securities analyst Gregory Renza maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a
Top Wall Street analysts upgraded FSLR, META, WM, NET, and REGN stocks. Check out analyst ratings pa
Benchmark analyst Robert Wasserman upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Hold to
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/